Pay in 4 interest-free payments of $6.17 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
Youll speak directly with our medical team to see if GLP-1 is appropriate and how monitoring would work
Eden: The Transparent $199 Flat Rate Eden publishes a month-by-month price table on its own homepage, unusual transparency in a category built on hidden refill costs
A GLP-1 agonist is the medication we are discussing in this post - exogenous sources of GLP-1 that have been shown to lower cardiac risk, improve A1c values, and, yes, help people rapidly lose weight
If you want to explore what this looks like for your population, connect with our Wondr Health team
E., & Berge, K
Regional Insights North America GLP-1 Receptor Agonist Market Insights North America dominated the global GLP-1 Receptor Agonist Market in 2025 with approximately 45% of global revenues, anchored entirely by the United States' unique drug pricing environment and the commercial investment that Novo Nordisk and Eli Lilly have made in building GLP-1 prescribing across endocrinology, primary care, cardiology, and bariatric medicine
